INTRA-CELLULAR THERAPIES INC.

Codice
itci
Risorse esterne
Opinione della community
Prezzo Variazione Volume
15.83 -1.62 €
(-9.28%)
166185
P/E Obiettivo ad 1anno
0 28.38 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 11
Sell : 5

frazito98 Jakob Peric

Commenti


Notizie

Technical Signal Analysis for Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - The Oracle Examiner

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)'s stock fluctuated in the range of $15.90 and $16.39 during the previous active session. Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) traded with the volume of 766679 with average volume of 846.3 Million. Leggi

Which Way Traders Signposts Celgene Corporation (CELG), Intra-Cellular Therapies, Inc. (ITCI) Stocks? - StockNewsJournal

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), stock is trading $42.40 above the 52-week high and has displayed a high EPS growth of -59.00% in last 5 years. The 1 year EPS growth rate is 7.30%. Its share price has risen 32.22% in three months and is ... Leggi

Intra-Cellular Therapies Inc (ITCI) EPS Estimated At $-0.53 - BZ Weekly

After posting $-0.41 EPS for the previous quarter, Intra-Cellular Therapies Inc's analysts now forecast 29.27 % negative EPS growth. The stock decreased 1.77% or $0.29 on October 13, reaching $16.09. About 547,969 shares traded. Intra-Cellular ... Leggi

Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Experiences Heavy ... - HugoPress

Trading volume for Intra-Cellular Therapies Inc. was 1306K in the last trading session. Volume was up 213.95% over the stocks average daily volume. Investors. Leggi

Technical Facts to Know: Intra-Cellular Therapies, Inc. (ITCI) traded -29.01% away from 52-Week High - Voice Of Analysts

Illumina, Inc. (ILMN) stock price is at a -3.57% downfall to its 52-week high and above 73.15% to a 52-week low. Analysts assigned mean rating at 2.40 (1.0 = Strong Buy, 5.0 = Sell). The trailing P/E is at 40.73. It trades with a Forward P/E valuation ...altro » Leggi

Intra-Cellular Therapies, Inc. (ITCI): Scrutinizing the Chart - Economic News

If, for instance, a stock's volumes suddenly increase by a significant amount, it's usually a sign that the level of conviction behind the trade is high. Investors may feel very strongly about the future direction of the stock in question. Intra ... Leggi

Analysts Layout Best- And Worst-Case Scenarios: Intra-Cellular Therapies, Inc. (ITCI), Macy's, Inc. (M) - Post Analyst

It was last traded at $15.78 apiece. Intra-Cellular Therapies, Inc. (ITCI): Outperform Candidate With 80.61% Upside Potential. Intra-Cellular Therapies, Inc. is maintained at an average outperform rating by 8 stock analysts, and there are at least 16 ... Leggi

The SunTrust Banks, Inc. Reaffirms “Hold” Rating for Intra-Cellular Therapies Inc. (ITCI) - BangaloreWeekly

Intra-Cellular Therapies Inc. (NASDAQ:ITCI)'s stock had its “hold” rating restated by research analysts at SunTrust Banks, Inc. in a research report issued to clients and investors on Friday. They currently have a ... 828,691 shares of the company ...altro » Leggi

Ghost Tree Capital Increases Stake in Intra Cellular Therapies (Call) (ITCI); Intl Business Machines (IBM) Shares ... - BZ Weekly

The stock decreased 1.77% or $0.29 on October 13, reaching $16.09. About 547,969 shares traded. Intra-Cellular Therapies Inc (NASDAQ:ITCI) has declined 68.76% since October 14, 2016 and is downtrending. It has underperformed by 85.46% the S&P500 ...altro » Leggi

Stock to Buy: Intra-Cellular Therapies, Inc. (ITCI) - Street Observer (press release)

Intra-Cellular Therapies, Inc. (ITCI) stock price traded with surging change along with the volume 0.37 million shares on Monday trading session. Shares are trading price at $19.80 with move of 2.64%. The company's 3-months average volume stands at 0 ... Leggi